loaderimg
image

Dimoveo is a pre-clinical stage medical device company that is developing a debridement device for cleaning and removing biofilm from the surgical cavity surrounding an implant. Dimoveo addresses the challenge of patients suffering from Post-TKA infection where current standard of care is ineffective. Dimoveo addresses the Global market, currently focusing on the US market with over 1.5M patients/year. Dimoveo is a portfolio company of MEDX Xelerator, backed by seed investment from Boston Scientific, MEDX Ventures and MEDX Xelerator.
For more information, contact Dimoveo’s CEO, Yair Ramot: [email protected].

Company’s Keywords:

Q How Many Employees Does This Company Have?

<1

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

<

Q What Year Was the Company Founded?

<2020

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image